Literature DB >> 32066555

Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database.

Thủy Nguyễn1, Alexandre Thibault Jacques Maria2,3, Philippe Guilpain4,3, Jean-Luc Faillie1, Chayma Ladhari1, Pascale Palassin1, Xavier Quantin5, Candice Lesage6, Guillaume Taïeb7, Xavier Ayrignac7, Patricia Rullier4, Dominique Hillaire-Buys1, Olivier Lambotte8.   

Abstract

Entities:  

Keywords:  autoimmune diseases; dermatomyositis; epidemiology; polymyositis

Mesh：

Substances：

Year:  2020        PMID： 32066555     DOI： 10.1136/annrheumdis-2020-217018

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.

Authors:  Yuki Nakagomi; Kazuko Tajiri; Saori Shimada; Siqi Li; Keiko Inoue; Yoshiko Murakata; Momoko Murata; Shunsuke Sakai; Kimi Sato; Masaki Ieda
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

Review 2.  Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Konstantinos Melissaropoulos; Kalliopi Klavdianou; Alexandra Filippopoulou; Fotini Kalofonou; Haralabos Kalofonos; Dimitrios Daoussis
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

3.  Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors.

Authors:  Zsofia D Drobni; Sean P Murphy; Raza M Alvi; Charlotte Lee; Jingyi Gong; Ramya C Mosarla; Paula K Rambarat; Sarah B Hartmann; Hannah K Gilman; Leyre Zubiri; Vineet K Raghu; Ryan J Sullivan; Amna Zafar; Daniel A Zlotoff; Meghan E Sise; Amanda C Guidon; Kerry L Reynolds; Michael Dougan; Tomas G Neilan
Journal:  Immunother Adv       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.